These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19364285)

  • 21. [Recent progress in adenovirus vectors: focusing on VA-deleted AdV].
    Kondo S; Maekawa A; Saito I; Kanegae Y
    Uirusu; 2013; 63(2):155-64. PubMed ID: 25366050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.
    Sprinzl MF; Oberwinkler H; Schaller H; Protzer U
    J Virol; 2001 Jun; 75(11):5108-18. PubMed ID: 11333892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
    Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
    Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV.
    Montenegro-Miranda PS; Pichard V; Aubert D; Ten Bloemendaal L; Duijst S; de Waart DR; Ferry N; Bosma PJ
    Gene Ther; 2014 Feb; 21(2):168-74. PubMed ID: 24285217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice.
    Rauschhuber C; Xu H; Salazar FH; Marion PL; Ehrhardt A
    J Gene Med; 2008 Aug; 10(8):878-89. PubMed ID: 18470951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of the recombinant genomes of woodchuck hepatitis virus in the mouse model.
    Pan D; Lin Y; Wu W; Song J; Zhang E; Wu C; Chen X; Hu K; Yang D; Xu Y; Lu M
    PLoS One; 2015; 10(5):e0125658. PubMed ID: 25942393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes.
    Hokanson CA; Dora E; Donahue BA; Rivkin M; Finer M; Mendez MJ
    Hum Gene Ther; 2003 Mar; 14(4):329-39. PubMed ID: 12659674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foamy virus--adenovirus hybrid vectors.
    Picard-Maureau M; Kreppel F; Lindemann D; Juretzek T; Herchenröder O; Rethwilm A; Kochanek S; Heinkelein M
    Gene Ther; 2004 Apr; 11(8):722-8. PubMed ID: 14724670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region.
    Ono HA; Le LP; Davydova JG; Gavrikova T; Yamamoto M
    Cancer Res; 2005 Nov; 65(22):10154-8. PubMed ID: 16287998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo.
    Ehrhardt A; Xu H; Kay MA
    J Virol; 2003 Jul; 77(13):7689-95. PubMed ID: 12805471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
    Sutton MA; Berkman SA; Chen SH; Block A; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Woo SL; Lerner SP
    Urology; 1997 Feb; 49(2):173-80. PubMed ID: 9037277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations.
    Alemany R; Dai Y; Lou YC; Sethi E; Prokopenko E; Josephs SF; Zhang WW
    J Virol Methods; 1997 Nov; 68(2):147-59. PubMed ID: 9389404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creation and repair of specific DNA double-strand breaks in vivo following infection with adenovirus vectors expressing Saccharomyces cerevisiae HO endonuclease.
    Nicolás AL; Munz PL; Falck-Pedersen E; Young CS
    Virology; 2000 Jan; 266(1):211-24. PubMed ID: 10612676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
    Wildner O; Hoffmann D; Jogler C; Uberla K
    Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
    J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus.
    Motoi F; Sunamura M; Ding L; Duda DG; Yoshida Y; Zhang W; Matsuno S; Hamada H
    Hum Gene Ther; 2000 Jan; 11(2):223-35. PubMed ID: 10680837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
    Kirby TO; Rivera A; Rein D; Wang M; Ulasov I; Breidenbach M; Kataram M; Contreras JL; Krumdieck C; Yamamoto M; Rots MG; Haisma HJ; Alvarez RD; Mahasreshti PJ; Curiel DT
    Clin Cancer Res; 2004 Dec; 10(24):8697-703. PubMed ID: 15623655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of a split-Cre system for high-capacity adenoviral vector amplification.
    Gonzalez-Aparicio M; Bunuales M; de Landazuri IO; Prieto J; Hernandez-Alcoceba R
    Biotechnol J; 2023 Mar; 18(3):e2200227. PubMed ID: 36478401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.